BETHESDA, Md., Aug. 31 /U.S. Newswire/ -- The first major multi- center, randomized, double-blind, placebo-controlled trial addressing therapy for gastroesophageal reflux disease (GERD) related sleep disorders was published today in the September issue of the American Journal of Gastroenterology.